Literature DB >> 28034762

Treatment of Sweat gland carcinoma with Topical Aminolevulinic Acid Photodynamic therapy: An effective treatment method to improve surgical outcomes.

Xian He1, Yadong Yang2, Yang Yang3, Yuanyuan Wang2, Wensheng Wang4, Yanying Song2, Yongfang Zeng2, Yunchuan Yang2, Xingcun Zhang5, Guoling Li2, Yang Gao6, Yuangang Lu7.   

Abstract

BACKGROUND: Sweat gland carcinoma is an extremely rare skin cancer, which is hard to diagnose and completely resect without causing functional and cosmetic problems. Moreover, the high rate of recurrence is hard to handle in the treatment of sweat gland carcinoma. Photodynamic therapy is a novel treatment protocol which can selectively destroy tumor cells with good functional and cosmetic outcomes.
METHODS: This is a case about a 53 years old patient with sweat gland carcinoma on his right foot, which received surgery and photodynamic therapy.
RESULTS: There is no recurrence one year after treatment of surgery and photodynamic therapy.
CONCLUSIONS: Excision combined with photodynamic therapy during operation is a promising strategy towards tumors which are hard to resect thoroughly and have a high risk of recurrence.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aminolevulinic acid; Efficacy; Surgery; Sweat gland carcinoma; Topical photodynamic therapy

Mesh:

Substances:

Year:  2016        PMID: 28034762     DOI: 10.1016/j.pdpdt.2016.12.004

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  2 in total

Review 1.  Reappraisal and literature review of primary cutaneous cribriform apocrine carcinoma.

Authors:  Anna Davis; Amor Khachemoune
Journal:  Arch Dermatol Res       Date:  2022-02-06       Impact factor: 3.017

Review 2.  A case of eccrine porocarcinoma characterized by a progressive increase in the level of Ki-67 index: case report and review of literature.

Authors:  Jie Shen; Xinfa Pan; Yongfu Lu; Desheng Pan; Yuehui Ma; Renya Zhan
Journal:  BMC Surg       Date:  2019-10-10       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.